Koch Michael, Zenk Johannes, Iro Heinrich
Department of Otorhinolaryngology, Head and Neck Surgery, Friedrich Alexander University of Erlangen-Nuremberg, Waldstrasse 1, 91054 Erlangen, Germany.
Otolaryngol Clin North Am. 2009 Dec;42(6):1173-92, Table of Contents. doi: 10.1016/j.otc.2009.08.002.
Treatment of obstructive diseases of the major salivary glands has undergone a dramatic change in the last 10 to 15 years. New minimally invasive techniques have been developed, covering all different entities that are included in the complex of salivary gland obstruction, and can help the physician to find the right diagnosis and an adequate treatment plan and to perform a gland-preserving form of therapy. Sialolithiasis or stenosis is the cause of about 90% of all obstructive salivary gland diseases. The development of radiologically or fluoroscopically controlled methods, but especially the introduction of sialendoscopy, has led to changes in the treatment protocol. Knowledge from the authors' experience and from a thorough investigation of the literature has been combined to elaborate algorithms for the treatment of the different obstructive diseases of the salivary glands. Sialoliths and stenoses can be successfully treated by radiologically or fluoroscopically controlled or sialendoscopically based methods in approximately 80% of cases. Extracorporeal shock-wave lithotripsy (ESWL) is successful in up to 50% of cases. Transoral duct slitting is an important method for extraparenchymal submandibular stones, with a success rate of 90%. Operative duct procedures and the combined endoscopic-transcutaneous approach complete the spectrum of treatment modalities of the parotid gland. Sialendoscopy plays a central role in the treatment of obstructive salivary gland diseases, but maximum success can only be attained by the reasonable combination of all these new minimally invasive techniques. Altogether, in well over 95% of cases, resection of the gland can be prevented, thus reducing morbidity and the surgical risks for patients.
在过去10至15年中,大唾液腺阻塞性疾病的治疗发生了巨大变化。已开发出新的微创技术,涵盖唾液腺阻塞综合征中包含的所有不同实体,可帮助医生做出正确诊断并制定适当的治疗方案,并实施保留腺体的治疗方式。涎石病或狭窄是所有阻塞性唾液腺疾病中约90%的病因。放射学或荧光镜控制方法的发展,尤其是唾液腺内镜的引入,导致了治疗方案的改变。作者的经验和对文献的深入研究相结合,制定了唾液腺不同阻塞性疾病的治疗算法。涎石和狭窄大约80%的病例可通过放射学或荧光镜控制或基于唾液腺内镜的方法成功治疗。体外冲击波碎石术(ESWL)在高达50%的病例中取得成功。经口导管切开术是治疗腺体外下颌下腺结石的重要方法,成功率为90%。手术导管操作以及内镜-经皮联合方法完善了腮腺治疗方式的范围。唾液腺内镜在阻塞性唾液腺疾病的治疗中起着核心作用,但只有合理组合所有这些新的微创技术才能取得最大成功。总体而言,在超过95%的病例中,可以避免腺体切除,从而降低患者的发病率和手术风险。